| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 9.834 | 36.494 | 54.583 | 76.551 | 96.178 |
| Total Income - EUR | - | - | - | - | - | 10.122 | 36.782 | 54.589 | 76.552 | 98.100 |
| Total Expenses - EUR | - | - | - | - | - | 16.801 | 26.844 | 29.018 | 39.908 | 50.146 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -6.680 | 9.938 | 25.571 | 36.643 | 47.954 |
| Net Profit/Loss - EUR | - | - | - | - | - | -6.777 | 9.716 | 25.052 | 35.943 | 45.453 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Diab Medicals By Dr. Máté S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 5.231 | 5.474 | 21.721 | 15.599 | 148.174 |
| Current Assets | - | - | - | - | - | 3.624 | 8.675 | 11.866 | 51.786 | 11.679 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 980 |
| Receivables | - | - | - | - | - | 497 | 850 | 3.853 | 5.868 | 531 |
| Cash | - | - | - | - | - | 3.127 | 7.826 | 8.013 | 45.918 | 10.168 |
| Shareholders Funds | - | - | - | - | - | -6.735 | 3.130 | 28.192 | 60.006 | 94.167 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 15.591 | 11.019 | 5.430 | 7.397 | 65.739 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diab Medicals By Dr. Máté S.r.l.